ADVFN - Advanced Financial Network.
HOME» NYSE » P » PFE Stock Price » PFE Stock News

Pfizer Share News

 Pfizer Stock Price
PFE Stock Price
 Pfizer Stock Chart
PFE Stock Chart
 Pfizer Stock News
PFE Stock News
 Pfizer Company Information
PFE Company Information
 Pfizer Stock Trades
PFE Stock Trades

WSJ BLOG/Health: A.M. Vitals: NFL Retirees File Suit on Head Injuries

(This story has been posted on The Wall Street Journal Online's Health Blog at By Stefanie Ilgenfritz Here's what's making health news this morning: NFL Retirees File Single Suit for Head Injuries (WSJ): In the complaint, lawyers for more than 2,300 retired players in 86 suits alleged that for decades the NFL hid the risks of such injuries and ignored mounting evidence of the long-term effects that football-related concussions can have, including dementia and chronic depression. Pfizer Prepares for IPO of Animal Health Unit (WSJ): The New York drug maker also disclosed a new name for the animal-health business, Zoetis, which Pfizer said is based on the root "zo" found in animal-related words such as zoo and zoology. Former Coke Executive Slams 'Share of Stomach' Marketing Campaign (Washington Post): Todd Putnam, a former marketing executive at Coca-Cola, now regrets his work and says it contributed to the nation's obesity problem. 6.6 Million Young Adults on Parents' Health Plans, Survey Says (LA Times): That number, found in a survey by the nonprofit Commonwealth Fund, is far higher than earlier estimates. Arizona Tries to Keep Reins Tight as It Starts Regulating Medical Marijuana (NY Times): In Arizona, dispensaries have to abide by zoning regulations that change from one municipality to the next; applicants must offer detailed plans on how to secure, store and track the marijuana; and they have to offer educational materials and hire a medical director to supervise. Suicide Among U.S. Troops Averaging One a Day in 2012 (USA Today): The 154 suicides for active-duty troops in the first 155 days of the year far outdistance the U.S. forces killed in action in Afghanistan -- about 50% more -- according to Pentagon statistics obtained by the Associated Press. -For continuously updated news from The Wall Street Journal, see at

Stock News for Pfizer (PFE)
10/21/201614:06:01Amended Statement of Beneficial Ownership (3/a)
10/21/201611:55:00FDA Approves Supplemental New Drug Application for XTANDI® (enzalutamide...
10/20/201608:00:00Debiopharm International SA Announces Clinical Collaboration...
10/20/201608:00:00Debiopharm International SA Announces Clinical Collaboration...
10/19/201618:02:00CDC Advisory Committee on Immunization Practices Votes to Recommend...
10/19/201608:00:00Pfizer Awarded Grant to Evaluate Vaccine to Protect Newborns...
10/19/201603:03:00J&J Brushes Off Pfizer's Challenge -- WSJ
10/18/201612:43:00J&J Brushes off Looming Biosimilar Competition -- 2nd Update
10/18/201608:16:54Statement of Changes in Beneficial Ownership (4)
10/18/201608:16:54Statement of Changes in Beneficial Ownership (4)
10/18/201608:16:54Statement of Changes in Beneficial Ownership (4)
10/18/201608:16:25Statement of Changes in Beneficial Ownership (4)
10/17/201619:16:00Pfizer Plans to Launch Remicade Biosimilar in November -- Update
10/17/201618:40:00Pfizer Plans to Launch Remicade Biosimilar in November
10/17/201618:36:00JPMorgan Sees $1 Billion In Lost J&J Sales On Pfizer Biosimilar...
10/17/201618:06:00Pfizer Plans to Launch Remicade Biosimilar in November
10/17/201616:05:00Pfizer Announces The U.S. Availability Of Biosimilar INFLECTRA®...
10/15/201610:30:00Pfizer to Present New Data on XELJANZ® (Tofacitinib Citrate...
10/13/201607:40:00Pfizer Loses UK Appeal Court Patent Case Over Lyrica
10/10/201607:23:00Pfizer Says Kidney Drug Extends Disease-Free Survival in Adjuvant...

Pfizer and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations